Biogen Inc. buy matumba
Start price
07.12.11
/
50%
€83.50
Target price
10.05.12
€102.75
Performance (%)
23.28%
End price
10.05.12
€102.94
Summary
This prediction ended on 10.05.12 with a price of €102.94. The prediction had a final performance of 23.28%. matumba has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | -7.317% | -7.317% | 51.972% | -31.392% |
| iShares Core DAX® | -2.680% | 2.021% | 3.062% | 56.109% |
| iShares Nasdaq 100 | 0.725% | 2.753% | 34.396% | 92.063% |
| iShares Nikkei 225® | -0.725% | 5.698% | 63.753% | 79.139% |
| iShares S&P 500 | 1.166% | 4.063% | 25.141% | 70.019% |
Comments by matumba for this prediction
In the thread Biogen Inc. diskutieren
38% Gewinnsteigerung
38% Gewinnsteigerung im 3. Quartal, der älteste Biotechunternehmer läßt die Mitbewerber alt aussehen.